3 ASCO Updates Tackle Treatment and Supportive Care Questions

Ben Leach
Published: Friday, Nov 04, 2011

Stage 1A

lymph nodes and breast cancer

Robert Morreale/Visual Explanations, LLC © 2005-2011 American Society of Clinical Oncology (ASCO)

Breast Cancer

Canadian Agency’s Outlook on Ovarian Ablation Endorsed

In keeping with its policy of endorsing guidelines developed by other organizations deemed appropriate, an American Society of Clinical Oncology (ASCO) ad hoc panel has voiced agreement with clinical guidelines established by Cancer Care Ontario (CCO) on adjuvant ovarian ablation (OA) for premenopausal women with earlystage invasive breast cancer.

Lung Cancer

Chemotherapy Limits for Stage IV Patients Weighed

An ASCO update committee recommended that patients with stage IV non-small cell lung cancer who have received 4 cycles of first-line chemotherapy and whose disease has not progressed could be immediately switched to alternative, single-agent chemotherapy to extend progression-free survival and, potentially, overall survival.

Supportive Care

Review of Antiemetic Therapies Yields New Recommendations

In its first review of antiemetic therapies since 2006, an ASCO committee tackled key clinical questions involving chemotherapyinduced and radiation-induced nausea and vomiting, clarifying language and refining guidelines in several areas.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication